Faecalicatena sp.
DSM 102166
Name:
"Faecalicatena sp."
DSM No.:
102166 dsm-102166 dsm102166 dsm 102166 Faecalicatena sp.
Strain designation:
Sanger_97
Isolated from:
faeces from healthy human
Country:
United Kingdom of Great Britain and Northern Ireland
Cambridgeshire
Cambridgeshire
Date of sampling:
06.12.2013
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Sanger_97
Genbank accession numbers:
draft genome (raw reads): ERR 1022277
Cultivation conditions:
Medium 1203a , anaerobic, 37°C
or
Medium 104 + haemin + VitK, anaerobic, 37°C
Incubation time: 2-3 days
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
or
Medium 104 + haemin + VitK, anaerobic, 37°C
Incubation time: 2-3 days
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
additional information:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Sanger_97. Faeces from healthy human; United Kingdom of Great Britain and Northern Ireland, Cambridgeshire; sampling date: 06.12.2013. Sequence accession no. draft genome (raw reads): ERR 1022277 (30548). (Medium 1203a, 37°C, anaerobic or Medium 104 + haemin + VitK, 37°C, anaerobic).
Literature:
Risk group:
1 (provisional classification by DSMZ)
Supplied as:
Delivery form | Prices | ||
Freeze Dried | 100,- € | ||
Active culture on request | 240,- € | ||
DNA | 150,- € | ||
Price Category for this culture: 1 |
Freight and handling charges will be added. See price list.
Other cultures: